Clinical Trials
8
Active:0
Completed:8
Trial Phases
3 Phases
Phase 1:1
Phase 3:1
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (71.4%)Phase 1
1 (14.3%)Phase 3
1 (14.3%)Hydrus Microstent for Refractory Open-Angle Glaucoma
Not Applicable
Completed
- Conditions
- Open-angle Glaucoma
- First Posted Date
- 2017-08-30
- Last Posted Date
- 2023-12-14
- Lead Sponsor
- Ivantis, Inc.
- Target Recruit Count
- 217
- Registration Number
- NCT03267134
- Locations
- 🇺🇸
Vold Vision, Fayetteville, Arkansas, United States
🇺🇸Sacramento Eye Consultants, Sacramento, California, United States
🇺🇸Eye Center of Northern Colorado, Fort Collins, Colorado, United States
Safety and Efficacy Study of the Hydrus Aqueous Implant in Subjects With POAG
Phase 1
Completed
- Conditions
- Primary Open Angle Glaucoma
- Interventions
- Drug: prestudy topical glaucoma medications
- First Posted Date
- 2017-02-27
- Last Posted Date
- 2019-02-04
- Lead Sponsor
- Ivantis, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT03065036
- Locations
- 🇦🇹
University Medical Center Vienna, Vienna, Austria
🇩🇪Aurelios Augenzentrum, Recklinghausen, Erlbruch, Germany
🇩🇪Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Augenklinik und Poliklinik, Mainz, Germany
Comparing Hydrus Microstent(TM) to the iStent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery
Not Applicable
Completed
- Conditions
- Primary Open Angle GlaucomaPseudoexfoliative GlaucomaPigmentary Dispersion Glaucoma
- First Posted Date
- 2013-12-31
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Ivantis, Inc.
- Target Recruit Count
- 306
- Registration Number
- NCT02024464
Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes
Not Applicable
Completed
- Conditions
- Primary Open Angle GlaucomaPseudoexfoliative GlaucomaPigmentary Glaucoma
- First Posted Date
- 2013-12-30
- Last Posted Date
- 2019-12-10
- Lead Sponsor
- Ivantis, Inc.
- Target Recruit Count
- 152
- Registration Number
- NCT02023242
- Locations
- 🇺🇸
Contact Richard Hope at Ivantis, Irvine, California, United States
Safety and Efficacy Trial to Evaluate the Hydrus(TM) Implant in Subjects Undergoing Cataract Surgery.
Not Applicable
Completed
- Conditions
- Cataract Unilateral Pending ExtractionGlaucoma, Open Angle, Pseudo-exfoliativePrimary Open Angle Glaucoma
- First Posted Date
- 2013-03-26
- Last Posted Date
- 2019-02-04
- Lead Sponsor
- Ivantis, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT01818115
- Locations
- 🇪🇸
See Central Contact, Zaragoza, Spain
- Prev
- 1
- 2
- Next
News
No news found